Cargando…

S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY

Detalles Bibliográficos
Autores principales:	Locatelli, Franco, Antmen, Bulent, Kang, Hyoung Jin, Koh, Katsuyoshi, Takahashi, Yoshiyuki, Kupesiz, Alphan, Matos, Maria Gabriela, Wall, Donna, Bhat, Sunil, Im, Ho Joon, Gungor, Tayfun, Lu, Meng-Yao, Stefanelli, Tommaso, Rosko, Christine, Pierre, Annie St., Burock, Karin, Diaz-De-Heredia, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Oral Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428409/ http://dx.doi.org/10.1097/01.HS9.0000967892.54405.ff

Ejemplares similares

Gene therapy in haemophilia: literature review and regional perspectives for Turkey
por: Kavaklı, Kaan, et al.
Publicado: (2022)

Multidisciplinary Management of Pediatric Hepatoblastoma: A 20-Year Single-Center Experience
por: Tayfun Küpesiz, Funda, et al.
Publicado: (2022)

Alterations of panoramic radiomorphometric indices in children and adolescents with beta-thalassemia major: A fractal analysis study
por: Yagmur, Burcu, et al.
Publicado: (2022)

Evaluation the oral hygiene conditions, oral Candida colonization and salivary Streptococcus mutans and Lactobacilli density in a group of β-thalassemic children and adolescence
por: Karayilmaz, Hüseyin, et al.
Publicado: (2019)

MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis
por: Mascarenhas, John, et al.
Publicado: (2023)

Hematopoietic Stem Cell Transplantation Activity and Trends at a Pediatric Transplantation Center in Turkey During 1998-2008
por: Hazar, Volkan, et al.
Publicado: (2012)

245th IAU Symposium 245 on Formation and Evolutions of Galaxy Bulges
por: International Astronomical Union
Publicado: (2007)

Impact of the HEAD-US Scoring System for Observing the Protective Effect of Prophylaxis in Hemophilia Patients: A Prospective, Multicenter, Observational Study
por: Kavaklı, Kaan, et al.
Publicado: (2021)

Ruxolitinib for myelofibrosis
por: GU, LIAN, et al.
Publicado: (2013)

Health Tract, No. 245: Symptoms
Publicado: (1866)

Ruxolitinib: Thrombocytopenia following compassionate use of ruxolitinib: 2 case reports
Publicado: (2022)

245__: CMS Collaboration - Part 2
por: Della Negra, Michel
Publicado: (1992)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

P1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID-SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID-REFRACTORY/DEPENDENT CHRONIC GRAFT-VS-HOST DISEASE
por: Zeiser, R., et al.
Publicado: (2022)

A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis
por: Harrison, Claire, et al.
Publicado: (2022)

Pediatric Tonsillar Synovial Sarcoma- Very Rare Localization: A Case Report and Review of the Literature
por: Yalçın, Koray, et al.
Publicado: (2020)

P1030: MANIFEST-2, A GLOBAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROL STUDY OF PELABRESIB (CPI-0610) AND RUXOLITINIB VS PLACEBO AND RUXOLITINIB IN JAK INHIBITOR-NAÏVE MYELOFIBROSIS PATIENTS
por: Harrison, C., et al.
Publicado: (2022)

Epidemiological Analysis of 245 Patients with Athletic Pubalgia
por: Goes, Rodrigo Araujo, et al.
Publicado: (2022)

Ruxolitinib in Myelofibrosis and Polycythemia Vera
por: Wolfe, Leah
Publicado: (2016)

Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor
por: Manduzio, Palma
Publicado: (2017)

Coccidioidomycosis in Patients Treated With Ruxolitinib
por: Kusne, Yael, et al.
Publicado: (2020)

Ruxolitinib for the Treatment of Essential Thrombocythemia
por: Gunawan, Arief, et al.
Publicado: (2018)

Ruxolitinib and Severe COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

P1005: A PHASE 1, OPEN-LABEL, DOSE-ESCALATION STUDY OF SELINEXOR PLUS RUXOLITINIB IN PATIENTS WITH TREATMENT-NAÏVE MYELOFIBROSIS
por: Ali, H., et al.
Publicado: (2022)

Searches for rare charm decays at LHCb (abstract 245)
por: Contu, Andrea
Publicado: (2016)

Preparación de furanos 2.4.5-Trisustituidos
por: Vergel Gámez, Hermila
Publicado: (1986)

2,4,5-Trimethoxybenzaldehyde monohydrate
por: Asiri, Abdullah M., et al.
Publicado: (2010)

Sonatina for flute and piano, B.W.I 245 /

245 Use of the CT Navigation in the Rhinology and Head Surgery
por: Fundova, Petra, et al.
Publicado: (2012)

M245. AN RCT PROTOCOL OF HYBRID-ECT FOR SCHIZOPHRENIA
por: Rong, Han
Publicado: (2020)

Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis
por: Verstovsek, S, et al.
Publicado: (2016)

Ruxolitinib therapy and telomere length in myelofibrosis
por: Caocci, G, et al.
Publicado: (2016)

Management of myelofibrosis after ruxolitinib failure
por: Harrison, Claire N, et al.
Publicado: (2020)

Ruxolitinib withdrawal due to the COVID-19
por: Lucijanic, Marko, et al.
Publicado: (2021)

Ruxolitinib: Extreme thrombocytosis: case report
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review
por: Appeldoorn, T. Y. J., et al.
Publicado: (2023)

Topical ruxolitinib for the treatment of granuloma faciale
por: Wong, Alan, et al.
Publicado: (2023)

Ruxolitinib cream for the treatment of cutaneous sarcoidosis
por: Smith, Jeffrey S., et al.
Publicado: (2023)

Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies
por: Gong, Xiaohua, et al.
Publicado: (2021)

Lophine (2,4,5-triphenyl-1H-imidazole)
por: Yanover, Diana, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0krgjvsc52lb85p5sbgeamedq9